RVL Pharmaceuticals plc Ordinary Shares
RVLP
RVLP was delisted on the 20th of October, 2023.
38 hedge funds and large institutions have $22.2M invested in RVL Pharmaceuticals plc Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
6% more funds holding
Funds holding: 36 → 38 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $27.8M → $22.2M (-$5.59M)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$123K |
| 2 |
Millennium Management
New York
|
+$69.7K |
| 3 |
State Street
Boston,
Massachusetts
|
+$48.4K |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$36.2K |
| 5 |
TC
Titleist Capital
San Antonio,
Texas
|
+$21.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$212K |
| 2 |
Two Sigma Investments
New York
|
-$93.5K |
| 3 |
Morgan Stanley
New York
|
-$77K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15.9K |
| 5 |
AWS
Atria Wealth Solutions
New York
|
-$12.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SWA
26
SFMG Wealth Advisors
Plano,
Texas
| $14K | +$14.5K | +10,000 | New |
|
|
TVWM
27
Tower View Wealth Management
Shorewood,
Wisconsin
| $6K | – | – | – |
|
28
Group One Trading
Chicago,
Illinois
| $3K | – | – | – |
|
|
HNB
29
Huntington National Bank
Columbus,
Ohio
| $2K | – | – | – |
|
30
Osaic Holdings
Scottsdale,
Arizona
| $2K | – | – | – |
|
31
Simplex Trading
Chicago,
Illinois
| $2K | +$2.31K | +1,598 | New |
|
32
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1K | – | – | – |
|
33
BNP Paribas Financial Markets
Paris,
France
| $10 | -$145 | -100 | -93% |
|
|
34
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$15.9K | -10,954 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| – | -$5K | -3,022 | Closed |
|
36
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2.96K | -2,043 | -96% |
|
|
AF
37
Allworth Financial
Folsom,
California
| – | +$109 | +75 | New |
|
RVLP Hedge Fund Activity: Q2 2022 in Review
38 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q2 2022, worth a combined $22.2M — down 20% from $27.8M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new RVLP positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 10 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $123K. The largest seller was Renaissance Technologies, cutting an estimated $212K.
- 38 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q2 2022, up from 36 in Q1 2022.
- Funds reported $22.2M of RVL Pharmaceuticals plc Ordinary Shares stock for Q2 2022, down 20% quarter-over-quarter.
- 6 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q2 2022 and 3 closed out, a net change of +3 holders.
- The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q2 2022 was AIGH Capital Management, an estimated $123K added.
- The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q2 2022 was Renaissance Technologies, an estimated $212K sold.
Based on aggregated 13F filings for Q2 2022.